Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in preventing AF recurrence after ablation in elderly hypertensive patients
NCT05528419Phase 4Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in Atrial fibrillation (AFib), sponsored by Shanghai Jiao Tong University School of Medicine. Started Feb 2023; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05528419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05528419.